The presented package image matches the product design registered with the Ukrainian regulatory authorities.
If you have noticed any differences, please call us at +380 44 490 75 22
Powder for injection intramuscular adm.
1 vial contains kanamycin acid sulfate sterile recalculated to kanamycin 1 g.
Severe purulent-septic diseases (sepsis, meningitis, peritonitis, septic endocarditis); infectious-inflammatory respiratory disease (pneumonia, pleural empyema, lung abscess); infections of the kidneys and urinary tract; suppurative complications in the postoperative period; infected burns; tuberculosis of the lungs and other organs tuberculous lesions caused by microorganisms resistant to antituberculous drugs I and II series and sensitive to kanamycin.
If you have information about any adverse effects or other drug-related problems, please fill in the form